info@shantani.com | Tel: +91-20-64103918, +91-20-64009991


 

Partnerships & Collaborations

Shantani is keen to explore strategic partnerships based on its chemical proteomics technologies. These include:

Some of our active collaborations are listed below:




The National Chemical Laboratory (NCL), India is a research, development and consulting organization with a focus on chemistry and chemical engineering. It has a successful record of research partnership with industry. NCL belongs to the family of Council of Scientific and Industrial Research (CSIR), the largest chain of public funded research organization in world. NCL's human resources comprise of over 1000 people of which 350 are scientist, 110 are technical staff with advanced degrees in science, technology or engineering.
The Centre for Cellular and Molecular Platforms (C-CAMP), is a Dept. of Biotechnology (Govt. of India) initiative and a not for profit organisation, that also forms an important part of the Bangalore Bio-cluster. C-CAMP acts as an enabler of bioscience research and entrepreneurship by providing research, development, training and service in state of the art technology platforms.
VLife Sciences Technologies is a leading provider of licensed software and research solutions for research projects in a variety of sectors including genotoxicity predictions . The software offers numerous unique and specialized features for applications in computer aided molecular discovery, bioinformatics, biotechnology and chemoinformatics. Technologies developed by VLife are unique, novel and offer advantages in terms of speed and accuracy thus leading to improved outcome from research projects.
"TCG Lifesciences Limited (formerly "Chembiotek Research International") is a leading contract research services company in the area of early drug discovery and development. TCG's services span from specific solutions to integrated discovery projects across multiple therapeutic areas with focus on Central Nervous System (CNS), Inflammation & Pain, Metabolic Disorders and Infectious Diseases; with a track record of delivery of pre-clinical candidates and lead molecules."
The Global Commercialization Group at the IC2 Institute, University of Texas at Austin, facilitates the growth and development of innovative technology-based businesses in a variety of regions worldwide. GCG programs simultaneously provide commercialization know-how to local partner organizations while proactively moving science and innovation from the region into international markets. This dual approach to economic development results in sustainable wealth-creating systems with measurable results in international business.